Anzeige
Mehr »
Sonntag, 06.07.2025 - Börsentäglich über 12.000 News
LiquidLink startet Bitcoin Lightning- und XRP-ILP-Nodes - Aufbau des Rückgrats der tokenisierten Finanzwelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
164 Leser
Artikel bewerten:
(0)

Five Things Nobel Prize Laureate Gregg Semenza Wishes Everyone Knew About Science

BALTIMORE, Dec. 3, 2019 /PRNewswire/ -- On Dec. 10, Johns Hopkins scientist Gregg Semenza will accept the 2019 Nobel Prize in Physiology or Medicine in Stockholm, Sweden - along with scientists William G. Kaelin, Jr. and Peter J. Ratcliffe - for his groundbreaking discovery of the gene that controls how cells respond to low oxygen levels.

Gregg Semenza won the 2019 Nobel Prize in Physiology or Medicine for for his groundbreaking discovery of the gene that controls how cells respond to low oxygen levels.

In the two months since the award was announced, Semenza has done scores of media interviews and lectures to audiences around the world about the implications of this work in understanding and eventually treating blood disorders, blinding eye diseases, cancer, diabetes, coronary artery disease and other conditions.

Beyond his research, here are five points Semenza, the C. Michael Armstrong Professor at the Johns Hopkins University School of Medicine, wishes more people knew about science.

Many of the best discoveries are made by young scientists: The Nobel Prizes are usually given to older scientists for discoveries they made as younger scientists. Because of this, Semenza says people may think that good science is solely the domain of older people, but great discoveries are often made by young scientists. "We often make these findings early in our careers, but it is only much later that the significance of those discoveries becomes apparent," says Semenza.

Discoveries take perseverance and collaboration: A lot of science is taking small steps forward. Big leaps are often the result of collaboration. Semenza recalls that when he and his lab identified the HIF-1 gene, which controls cells under low oxygen conditions, they initially ran into problems trying to clone the gene's DNA. Scientists clone DNA to learn more about a gene's function and other characteristics. He got help from fellow Johns Hopkins scientist Thomas Kelly who had expertise in a workaround approach: purifying the protein made by HIF-1, another way to learn more about the gene and its function in the cell.

The best research environments have mentorship and collegiality: "There are places with very smart people, and there are places where everybody is friendly. But there are few places with smart people who are almost always willing to help you. When we wrote the manuscript reporting the discovery of HIF-1, we submitted it to top-tier journals, and they did not find it to be of sufficient interest to warrant publication," says Semenza. But that didn't stop him: Semenza got help from late Johns Hopkins scientist Victor McKusick, and the paper was published in the Proceedings of the National Academy of Sciences. It has now been cited in over 6,000 scientific publications.

To advance science, invest in early education of science: "In high school, I had a biology teacher who inspired me and others to careers in scientific research by teaching us about the scientists and the scientific process that led to discoveries. She would often preface her description of a scientific discovery by saying 'when you win your Nobel Prize, I don't want you to forget that you learned that here,'" says Semenza. "We need to give more emphasis to teachers and reward them for the work that they do, which makes such a difference in the lives of so many."

Basic science research is good for the economy: "The inventions and discoveries that come out of basic research are critical for the economy, public health and treating disease earlier," says Semenza. "It is better, both for patients and for the economy, to treat diseases early rather than later, and we need more research to learn how to more effectively treat many cancers."

CONTACT: Alsy Acevedo, 410-464-6457, aaceved5@jhmi.edu

Photo - https://mma.prnewswire.com/media/1033276/Gregg_Semenza_2019_Nobel_Prize_Winner.jpg

© 2019 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.